Literature DB >> 11076533

Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.

B Razani1, Y Altschuler, L Zhu, R G Pestell, K E Mostov, M P Lisanti.   

Abstract

Squamous cell carcinomas of the lung and cervix arise by neoplastic transformation of their respective tissue epithelia. In the case of cervical carcinomas, an increasing body of evidence implicates the human papillomavirus, HPV (types 16 and 18), as playing a pivotal role in this malignant transformation process. The HPV early genes E6 and E7 are known to inactivate the tumor suppressors p53 and Rb, respectively; this leads to disruption of cell cycle regulation, predisposing cells to a cancerous phenotype. However, the role of caveolin-1 (a putative tumor suppressor) in this process remains unknown. Here, we show that caveolin-1 protein expression is consistently reduced in a panel of lung and cervical cancer derived cell lines and that this reduction is not due to hyperactivation of p42/44 MAP kinase (a known negative regulator of caveolin-1 transcription). Instead, we provide evidence that this down-regulation event is due to expression of the HPV E6 viral oncoprotein, as stable expression of E6 in NIH 3T3 cells is sufficient to dramatically reduce caveolin-1 protein levels. Furthermore, we demonstrate that p53-a tumor suppressor inactivated by E6-is a positive regulator of caveolin-1 gene transcription and protein expression. SiHa cells are derived from a human cervical squamous carcinoma, harbor a fully integrated copy of the HPV 16 genome (including E6), and show dramatically reduced levels of caveolin-1 expression. We show here that adenoviral-mediated gene transfer of the caveolin-1 cDNA to SiHa cells restores caveolin-1 protein expression and abrogates their anchorage-independent growth in soft agar. Taken together, our results suggest that the HPV oncoprotein E6 down-regulates caveolin-1 via inactivation of p53 and that replacement of caveolin-1 expression can partially revert HPV-mediated cell transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076533     DOI: 10.1021/bi001489b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc.

Authors:  Upal K Basu Roy; Rebecca S Henkhaus; Natalia A Ignatenko; Jessica Mora; Kimberly E Fultz; Eugene W Gerner
Journal:  Mol Carcinog       Date:  2008-12       Impact factor: 4.784

2.  Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.

Authors:  Zhi Zhao; Fang-Hai Han; Shi-Bin Yang; Li-Xin Hua; Jian-Hai Wu; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 3.  Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview.

Authors:  Samapika Routray
Journal:  Tumour Biol       Date:  2014-08-16

4.  HIV infection upregulates caveolin 1 expression to restrict virus production.

Authors:  Shanshan Lin; Xiao Mei Wang; Peter E Nadeau; Ayalew Mergia
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

5.  Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.

Authors:  Mulu Geletu; Zaid Taha; Rozanne Arulanandam; Reva Mohan; Hikmat H Assi; Maria G Castro; Ivan Robert Nabi; Patrick T Gunning; Leda Raptis
Journal:  Biochem Cell Biol       Date:  2019-04-15       Impact factor: 3.626

6.  Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts.

Authors:  Daniela Volonte; Kun Zhang; Michael P Lisanti; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

7.  Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.

Authors:  Franco Capozza; Terence M Williams; William Schubert; Steve McClain; Boumediene Bouzahzah; Federica Sotgia; Michael P Lisanti
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.

Authors:  Scott E Woodman; Anthony W Ashton; William Schubert; Hyangkyu Lee; Terence M Williams; Freddy A Medina; Jeffrey B Wyckoff; Terry P Combs; Michael P Lisanti
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.

Authors:  Hyangkyu Lee; David S Park; Babak Razani; Robert G Russell; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 10.  Clinical implications of caveolins in malignancy and their potential as therapeutic targets.

Authors:  Ila Tamaskar; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.